Benefits and Harms of Osteoporosis Medications in Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis.
Conclusion: Effects of osteoporosis medications on BMD, fracture risk, and safety among patients with CKD are not clearly established.
Primary Funding Source: Kidney Disease: Improving Global Outcomes.
PMID: 28395318 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Wilson LM, Rebholz CM, Jirru E, Liu MC, Zhang A, Gayleard J, Chu Y, Robinson KA Tags: Ann Intern Med Source Type: research
More News: Chronic Kidney Disease | Dialysis | Evista | Forteo | Internal Medicine | Kidney Transplant | Kidney Transplantation | Orthopaedics | Osteoporosis | PET Scan | Study | Transplant Surgery | Transplants | Urology & Nephrology | Women | Xgeva